Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency

NCT01223755 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

41

Enrollment

OTHER

Sponsor class

Stopped safety and efficacy reason

Conditions

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Interventions

DRUG: Sirolimus
DRUG: conventional therapy

Sponsor

Mario Negri Institute for Pharmacological Research